Genetic Testing Services Market Report Examines Industry Trends, Growth Drivers And Future Outlook

The genetic testing services market is on the brink of significant expansion, driven by advances in genomics and growing consumer interest in personalized healthcare. As technology becomes more integrated into routine medical care, this sector is poised to deliver new opportunities and innovations, reshaping how diseases are diagnosed and prevented worldwide.

Projected Size and Growth Trajectory of the Genetic Testing Services Market
The genetic testing services market is forecasted to reach a valuation of $34.09 billion by 2030, growing at a robust compound annual growth rate (CAGR) of 9.5%. This expansion is fueled by the increasing adoption of genomics in everyday healthcare, rising demand for personalized health information, and the broadening presence of digital health platforms. Additionally, clearer regulations around genetic testing services and a growing emphasis on preventive medicine are key contributors to this upward trend. Emerging market dynamics also include a surge in direct-to-consumer testing, greater use of disease risk assessments, broader prenatal and newborn genetic services, a heightened interest in ancestry testing, and more frequent utilization of genetic counseling.

The genetic testing services market size has grown rapidly in recent years. It will grow from $21.36 billion in 2025 to $23.75 billion in 2026 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to consumer interest in ancestry testing, availability of sequencing technologies, early adoption in academic research, growing awareness of inherited diseases, laboratory service expansion.

Download a free sample of the genetic testing services market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15385&type=smp&utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR

Prominent Players Leading the Genetic Testing Services Industry
A number of influential companies play a central role in shaping the genetic testing services landscape. These include F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific SE, SGS SA, Agilent Technologies, Hologic Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, NeoGenomics Laboratories Inc., 23andMe Holding Co, Berry Genomics Co. Ltd., Pacific Biosciences of California Inc., Ambry Genetics Corporation, Biocartis SA, CENTOGENE N.V., Blueprint Genetics Oy, Igenomix, and Veritas Genetics.

In a significant industry move, Tempus, a US-based precision medicine provider specializing in AI-driven clinical insights and oncology genetic testing, acquired Ambry Genetics in February 2025. This strategic acquisition aims to broaden Tempus's genetic testing capabilities by incorporating Ambry's hereditary disease testing services, thereby enhancing its platform for precision medicine and boosting its clinical genetic diagnostics presence. Ambry Genetics is well-known for delivering hereditary cancer, cardiovascular, pediatric, and rare disease testing solutions for both clinical and research purposes.

View the full genetic testing services market report:
https://www.thebusinessresearchcompany.com/report/genetic-testing-services-global-market-report?utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR

Technological Advances Fueling Growth in the Genetic Testing Services Market
Market leaders are increasingly investing in innovative technologies designed to improve test accuracy, broaden testing scopes, and enhance patient outcomes. Among the most notable advancements are cancer screening tests, which are routine exams conducted on asymptomatic individuals to detect early signs of cancer or precancerous conditions. Early detection through these screenings helps enable timely treatment, which can significantly improve success rates.

For example, in May 2025, Guardant Health, a US-based precision oncology diagnostics provider known for its blood-based liquid biopsies and genetic profiling, introduced the Guardant Hereditary Cancer test. This new service expands the company's genetic testing portfolio to include hereditary cancer risk assessments. The test features an 82-gene blood-based panel and can be combined with Guardant360 using the same patient sample, delivering results within 2 to 3 weeks for efficient inherited cancer risk identification.

Breaking Down the Genetic Testing Services Market Segmentation
This report outlines the genetic testing services market through multiple segmentation lenses:

1) By Type: Predictive Testing, Carrier Testing, Prenatal Testing, Newborn Screening, Other Types
2) By Disease: Cancer Disease, Metabolic Disease, Cardiovascular Disease, Other Diseases
3) By End User: Diagnostic Laboratories, Hospitals and Clinics, Academic Institutes and Research Centers, Other End Users

More detailed subcategories include:
- Predictive Testing: Cancer Predisposition Testing, Heart Disease Risk Testing, Neurological Disorder Risk Testing, Other Predictive Tests
- Carrier Testing: Carrier Screening for Single-Gene Disorders, Multifactorial Conditions, Inherited Genetic Conditions, and Other Carrier Tests
- Prenatal Testing: Non-Invasive Prenatal Testing (NIPT), Amniocentesis, Chorionic Villus Sampling (CVS), Ultrasound-Combined Genetic Testing, and Other Prenatal Tests
- Newborn Screening: Metabolic Disorder Screening, Genetic Disorder Screening, Hearing Loss Screening, Endocrine Disorder Screening, and Other Newborn Screening Tests
- Other Types: Pharmacogenetic Testing, Forensic Genetic Testing, Ancestry and Genetic Genealogy Testing, Paternity Testing, and Other Specialized Genetic Tests

This comprehensive segmentation allows for a deep understanding of the various testing types, diseases addressed, and end-user groups, highlighting the market's diverse and evolving nature.

Our latest 2026 market reports provide expanded strategic and visual intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, together with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.